Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
361
datasets available to search
ShareScore release 0.9.0
Dataset results
361 results for “RSV”
Cell Mediated Immunity Against RSV and Influenza in a Human Experimental Challenge
ClinicalTrials.gov study NCT02755948. IPD Sharing: NO. Countries: 1. Publications: 4.
Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to
ClinicalTrials.gov study NCT03102034. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With
ClinicalTrials.gov study NCT05045144. IPD Sharing: YES. Countries: 5. Publications: 1.
Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults
ClinicalTrials.gov study NCT04785612. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age
ClinicalTrials.gov study NCT03227029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection
ClinicalTrials.gov study NCT02534350. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
ClinicalTrials.gov study NCT02890381. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial
ClinicalTrials.gov study NCT05921903. IPD Sharing: YES. Countries: 8. Publications: 1.
A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS
ClinicalTrials.gov study NCT04071158. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers
ClinicalTrials.gov study NCT04605159. IPD Sharing: YES. Countries: 24. Publications: 3.
Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women
ClinicalTrials.gov study NCT02360475. IPD Sharing: YES. Countries: 4. Publications: 2.
A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults
ClinicalTrials.gov study NCT04090658. IPD Sharing: YES. Countries: 1. Publications: 1.
Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
ClinicalTrials.gov study NCT02911935. IPD Sharing: YES. Countries: 1. Publications: 2.
Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections
ClinicalTrials.gov study NCT05929599. IPD Sharing: YES. Countries: 1. Publications: 19.
Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
ClinicalTrials.gov study NCT04886596. IPD Sharing: YES. Countries: 17. Publications: 8.
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared
ClinicalTrials.gov study NCT06389487. IPD Sharing: YES. Countries: 6. Publications: 0.
Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
ClinicalTrials.gov study NCT00500578. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study
ClinicalTrials.gov study NCT04657198. IPD Sharing: YES. Countries: 2. Publications: 1.
Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of Clesrovimab (MK-1654) in Healthy Participants (MK-1654-005)
ClinicalTrials.gov study NCT04086472. IPD Sharing: YES. Countries: 1. Publications: 1.
MVA-BN-RSV Vaccine Trial
ClinicalTrials.gov study NCT05238025. IPD Sharing: NO. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.